Business Context and Reporting Period
Company: PainReform Ltd. (PRF Technologies Ltd.)
Filing Type: Form 6-K (Report of Foreign Private Issuer)
Date: September 11, 2024
Context: The Company entered into an inducement offer letter agreement on September 10, 2024, with holders of existing warrants to purchase ordinary shares. The transaction involves the exercise of existing warrants in exchange for the issuance of new warrants.
Key Financial Metrics
This filing details a capital raise transaction rather than periodic financial results. Key metrics related to the transaction include:
- Expected Gross Proceeds: Approximately $1.58 million from the exercise of existing warrants.
- Shares to be Issued (Existing Warrants): 989,300 ordinary shares.
- Exercise Price: $1.60 per ordinary share.
- New Warrants Issued: 1,978,600 new warrants (2x the number of shares purchased).
- Placement Agent Fees: 7.0% cash fee plus 1.0% management fee on gross proceeds, plus $25,000 for non-accountable expenses and $15,950 for clearing fees.
- Placement Agent Warrants: 69,251 warrants issued to the agent at an exercise price of $2.00 per share.
Note: The filing does not provide revenue, profit, cash flow, margins, debt, or liquidity metrics for the reporting period.
Material Changes
The primary material change is the restructuring of warrant obligations and the anticipated influx of capital:
- Warrant Exercise: Holders agreed to exercise 989,300 existing warrants (December 2023 and April 2024 issuances) for cash.
- Capital Injection: The Company expects to receive net proceeds for general corporate purposes.
- Dilution: The issuance of 1,978,600 new warrants and 69,251 placement agent warrants increases the potential dilution to existing shareholders.
Guidance, Outlook, and Risks
Management Commentary and Use of Proceeds: The Company intends to use net proceeds for general corporate purposes. The closing is expected on or about September 11, 2024, subject to customary conditions.
Risks and Contingencies:
- Closing Conditions: The transaction is subject to satisfaction of customary closing conditions; failure to meet these may prevent the offering from closing.
- Liquidity: There is no established trading market for the new warrants, and the Company does not expect one to develop, resulting in extremely limited liquidity for these instruments.
- Registration: The Company must file a resale registration statement for the new warrant shares and keep it effective until no holder owns the warrants.
- Lock-up Restrictions: The Company agreed not to issue ordinary shares or equivalents or file other registration statements for 30 days post-closing, and not to effect Variable Rate Transactions for one year post-closing.
Investor Verification Checklist
- Verify the actual closing date and confirmation of the $1.58 million gross proceeds receipt.
- Confirm the filing and effectiveness of the Resale Registration Statement (Form F-3) for the new warrant shares.
- Monitor the Company's cash position to ensure the proceeds are utilized for stated general corporate purposes.
- Review the impact of the 1,978,600 new warrants on future dilution if exercised at the $1.60 strike price.
- Check for any subsequent filings regarding the 30-day lock-up period on new share issuances.